Clinical trial
Study Evaluating Betaferons® Safety and Tolerability In Pediatric Patients With Multiple Sclerosis
NCT00963833 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study Evaluating Betaferons® Safety and Tolerability In Pediatric Patients With Multiple Sclerosis
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 17, 2009
- Completion date
- September 1, 2016
- Enrollment
- 68 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.